Cited by 118Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.

Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease: Rationale and Current Evidence

Tobinick, Edward·2009·CNS Drugs

DOI 10.2165/11310810-000000000-00000

Open this paper in CoChat — free account

Abstract

Tumour necrosis factor (TNF), a key regulator of varied physiological mechanisms in multiple organ systems, is an immune signalling molecule produced by glia, neurons, macrophages and other immune cells. In the brain, among other functions, TNF serves as a gliotransmitter, secreted by glial cells that envelope and surround synapses, which regulates synaptic communication between neurons. The role of TNF as a gliotransmitter may help explain the profound synaptic effects of TNF that have been demonstrated in the hippocampus, in the spinal cord and in a variety of experimental models. Excess TNF is present in the CSF of individuals with Alzheimer's disease (AD), and has been implicated as a mediator of the synaptic dysfunction that is hypothesized to play a central role in the pathogenesis of AD. TNF may also play a role in endothelial and microvascular dysfunction in AD, and in amyloidogenesis and amyloid-induced memory dysfunction in AD. Genetic and epidemiological evidence has implicated increased TNF production as a risk factor for AD. Perispinal administration of etanercept, a potent anti-TNF fusion protein, produced sustained clinical improvement in a 6-month, open-label pilot study in patients with AD ranging from mild to severe. Subsequent case studies have documented rapid clinical improvement following perispinal etanercept in both AD and primary progressive aphasia, providing evidence of rapidly reversible, TNF-dependent, pathophysiological mechanisms in AD and related disorders. Perispinal etanercept for AD merits further study in randomized clinical trials.

Integrity signals

Registry

Crossref · 10.2165/11310810-000000000-00000

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Activity-dependent scaling of quantal amplitude in neocortical neurons
Turrigiano, G. G., Leslie, K. R., Desai, N. S., Rutherford, L. C., & Nelson, S. B. (1998) · Nature · doi:10.1038/36103 · Cited by 2,226
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES
Batson, O. V. (1940) · Annals of Surgery · doi:10.1097/00000658-194007000-00016 · Cited by 1,930
Astrocytes, from brain glue to communication elements: the revolution continues
Volterra, A., & Meldolesi, J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1722 · Cited by 1,837
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Synaptic scaling mediated by glial TNF-α
Stellwagen, D., & Malenka, R. C. (2006) · Nature · doi:10.1038/nature04671 · Cited by 1,715
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D. E., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,658
Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation
Zonta, M., Angulo, M. C., Gobbo, S., Rosengarten, B., Hossmann, K.-A., Pozzan, T., & Carmignoto, G. (2002) · Nature Neuroscience · doi:10.1038/nn980 · Cited by 1,446
Control of Synaptic Strength by Glial TNFα
Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow, M., Beattie, M. S., & Malenka, R. C. (2002) · Science · doi:10.1126/science.1067859 · Cited by 1,344
Pathological verification of ischemic score in differentiation of dementias
Rosen, W. G., Terry, R. D., Fuld, P. A., Katzman, R., & Peck, A. (1980) · Annals of Neurology · doi:10.1002/ana.410070516 · Cited by 1,273
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Astrocyte-mediated control of cerebral blood flow
Takano, T., Tian, G.-F., Peng, W., Lou, N., Libionka, W., Han, X., & Nedergaard, M. (2005) · Nature Neuroscience · doi:10.1038/nn1623 · Cited by 1,137
TNF neutralization in MS
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,068
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985
The tripartite synapse: roles for gliotransmission in health and disease
Halassa, M. M., Fellin, T., & Haydon, P. G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.005 · Cited by 852
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J., Bertelsmann, F. W., Blomberg, B. M. E. V., Woody, J. N., Hartung, H., & Polman, C. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1531 · Cited by 735
β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
The role of microglia and macrophages in the pathophysiology of the CNS
Stollg, G., & Jander, S. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00083-5 · Cited by 683
Production of tumor necrosis factor-alpha by microglia and astrocytes in culture
Sawada, M., Kondo, N., Suzumura, A., & Marunouchi, T. (1989) · Brain Research · doi:10.1016/0006-8993(89)90078-4 · Cited by 631
Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.
Chung, I. Y., & Benveniste, E. N. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.8.2999 · Cited by 609
TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
Feldmann, M., & Maini, R. N. (2003) · Nature Medicine · doi:10.1038/nm939 · Cited by 586
Evidence for the involvement of TNF and NF-?B in hippocampal synaptic plasticity
Albensi, B. C., & Mattson, M. P. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200002)35:2 · Cited by 527
“Inflammatory” Cytokines: Neuromodulators in Normal Brain?
Vitkovic, L., Bockaert, J., & Jacque, C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740457.x · Cited by 506
Intrathecal inflammation precedes development of Alzheimer's disease
Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501
Acute p38-Mediated Modulation of Tetrodotoxin-Resistant Sodium Channels in Mouse Sensory Neurons by Tumor Necrosis Factor-α
Jin, X., & Gereau, R. W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3858-05.2006 · Cited by 488
Alzheimer's disease: Aβ, tau and synaptic dysfunction
LaFerla, F. M., & Oddo, S. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.02.009 · Cited by 477
The Ciba Collection of Medical Illustrations
(1955) · JAMA · doi:10.1001/jama.1955.02960040113036 · Cited by 472
Inflammatory markers and the risk of Alzheimer disease: The Framingham Study
Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000263217.36439.da · Cited by 440
Actions of TNF‐α on glutamatergic synaptic transmission in the central nervous system
Pickering, M., Cumiskey, D., & O'Connor, J. J. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2005.030734 · Cited by 421
TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NFκB inhibition
Zou, J., & Crews, F. T. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.014 · Cited by 410
The California Verbal Learning Test – second edition: Test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms
WOODS, S., DELIS, D., SCOTT, J., KRAMER, J., & HOLDNACK, J. (2006) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2006.06.002 · Cited by 401
Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice
He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390
Interferon-γ and Tumor Necrosis Factor-α Regulate Amyloid-β Plaque Deposition and β-Secretase Expression in Swedish Mutant APP Transgenic Mice
Yamamoto, M., Kiyota, T., Horiba, M., Buescher, J. L., Walsh, S. M., Gendelman, H. E., & Ikezu, T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060378 · Cited by 367
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
(1999) · PubMed · Cited by 355
Intracerebral Production of Tumor Necrosis Factor-α, a Local Neuroprotective Agent, in Alzheimer Disease and Vascular Dementia
Tarkowski, E., Blennow, K., Wallin, A., & Tarkowski, A. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020568013953 · Cited by 349
Astrocyte control of the cerebrovasculature
Gordon, G. R., Mulligan, S. J., & MacVicar, B. A. (2007) · Glia · doi:10.1002/glia.20543 · Cited by 339
Tumor necrosis factor alters synaptic transmission in rat hippocampal slices.
Tancredi, V., D'Arcangelo, G., Grassi, F., Tarroni, P., Palmieri, G., Santoni, A., & Eusebi, F. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90071-e · Cited by 326
Severe Impairment Battery
Panisset, M. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540130067012 · Cited by 325
Regulation of CNS synapses by neuronal MHC class I
Goddard, C. A., Butts, D. A., & Shatz, C. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702023104 · Cited by 322
Onset of multiple sclerosis associated with anti-TNF therapy
Sicotte, N. L., & Voskuhl, R. R. (2001) · Neurology · doi:10.1212/wnl.57.10.1885 · Cited by 322
Stimulation of Microglial Metabotropic Glutamate Receptor mGlu2 Triggers Tumor Necrosis Factor α-Induced Neurotoxicity in Concert with Microglial-Derived Fas Ligand
Taylor, D. L., Jones, F., Kubota, E. S. F. C. S., & Pocock, J. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-04.2005 · Cited by 308
The role of TNF and its receptors in Alzheimer's disease
Perry, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00291-3 · Cited by 301
Connecting TNF-α Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid β Protein
Medeiros, R., Prediger, R. D. S., Passos, G. F., Pandolfo, P., Duarte, F. S., Franco, J. L., Dafre, A. L., Di Giunta, G., Figueiredo, C. P., Takahashi, R. N., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5047-06.2007 · Cited by 292
Letter and category fluency in patients with frontal lobe lesions.
Baldo, J. V., & Shimamura, A. P. (1998) · Neuropsychology · doi:10.1037//0894-4105.12.2.259 · Cited by 285
TNFα plus IFNγ induce the production of Alzheimer β‐amyloid peptides and decrease the secretion of APPs
Blasko, I., Marx, F., Steiner, E., Hartmann, T., & Grubeck-Loebenstein, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.63 · Cited by 279
How TNF was recognized as a key mechanism of disease
Clark, I. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.04.002 · Cited by 273
The vertebral vein system. Caldwell lecture, 1956.
Batson, O. V. (1957) · PubMed · Cited by 273
TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study.
Tobinick, E. L., Gross, H., Weinberger, A., & Cohen, H. (2006) · PubMed · Cited by 271
Self-citation
β-Amyloid-Stimulated Microglia Induce Neuron Death via Synergistic Stimulation of Tumor Necrosis Factor α and NMDA Receptors
Floden, A. M., Li, S., & Combs, C. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4998-04.2005 · Cited by 254
Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration
Tobinick, E. L., & Gross, H. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-2 · Cited by 250
Self-citation
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice
Chang, E. H., Savage, M. J., Flood, D. G., Thomas, J. M., Levy, R. B., Mahadomrongkul, V., Shirao, T., Aoki, C., & Huerta, P. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507313103 · Cited by 225
Chronic Neuron-Specific Tumor Necrosis Factor-Alpha Expression Enhances the Local Inflammatory Environment Ultimately Leading to Neuronal Death in 3xTg-AD Mice
Janelsins, M. C., Mastrangelo, M. A., Park, K. M., Sudol, K. L., Narrow, W. C., Oddo, S., LaFerla, F. M., Callahan, L. M., Federoff, H. J., & Bowers, W. J. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080528 · Cited by 220
Vasculoprotective Effects of Anti-Tumor Necrosis Factor-α Treatment in Aging
Csiszár, A., Labinskyy, N., Smith, K. E., Rivera, A., Orosz, Z. Z., & Ungvari, Z. I. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060708 · Cited by 214
Short test of semantic and phonological fluency: Normal performance, validity and test‐retest reliability
Harrison, J., Buxton, P., Masud Husain, B., & Wise, R. (2000) · British Journal of Clinical Psychology · doi:10.1348/014466500163202 · Cited by 209
Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by β‐amyloid
Même, W., Calvo, C., Froger, N., Ezan, P., Amigou, E., Koulakoff, A., & Giaume, C. (2006) · The FASEB Journal · doi:10.1096/fj.05-4297fje · Cited by 202
The suboccipital cavernous sinus
Arnautović, K. I., Al‐Mefty, O., Pait, T. G., Krisht, A. F., & Husain, M. M. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.86.2.0252 · Cited by 201
The concept of long term potentiation of transmission at synapses
Bennett, M. R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00006-4 · Cited by 180
Anatomical and Pathological Considerations in Percutaneous Vertebroplasty and Kyphoplasty: A Reappraisal of the Vertebral Venous System
Groen, R. J. M., Toit, D. F. D., Phillips, F. M., Hoogland, P. V. J. M., Kuizenga, K., Coppes, M. H., Muller, C. J. F., Grobbelaar, M., & Mattysen, J. (2004) · Spine · doi:10.1097/01.brs.0000128758.64381.75 · Cited by 177
Two‐Photon Imaging of Astrocytic Ca2+ Signaling and the Microvasculature in Experimental Mice Models of Alzheimer's Disease
Takano, T., Han, X., Deane, R., Zloković, B. V., & Nedergaard, M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.004 · Cited by 174
Identification and characterization of receptors for tumor necrosis factor-α in the brain
Kinouchi, K., Brown, G. P., Pasternak, G. W., & Donner, D. B. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)92113-x · Cited by 170
Synaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction
Rowan, M. J., Klyubin, I. V., Wang, Q., Hu, N., & Anwyl, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351219 · Cited by 154
Glia: they make your memories stick!
Bains, J. S., & Oliet, S. H. R. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.007 · Cited by 145
Glia as a Therapeutic Target: Selective Suppression of Human Amyloid-β-Induced Upregulation of Brain Proinflammatory Cytokine Production Attenuates Neurodegeneration
Ranaivo, H. R., Craft, J. M., Hu, W., Guo, L., Wing, L. K., Eldik, L. J. V., & Watterson, D. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4652-05.2006 · Cited by 137
β‐amyloid inhibition of long‐term potentiation is mediated via tumor necrosis factor
Wang, Q., Wu, J., Rowan, M. J., & Anwyl, R. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04457.x · Cited by 134
Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic Impairment
Yang, T., Knowles, J. K., Lu, Q., Zhang, H., Arancio, O., Moore, L. A., Chang, T., Wang, Q., Andreasson, K. I., Rajadas, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003604 · Cited by 134
Role of IL-1 and TNF in the brain: Twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system
Gosselin, D., & Rivest, S. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.12.004 · Cited by 130
Enhanced Prospects for Drug Delivery and Brain Targeting by the Choroid Plexus–CSF Route
Johanson, C. E., Duncan, J. A., Stopa, E. G., & Baird, A. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6039-0 · Cited by 128
Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor α blockade
van Eijk, I. C., Peters, M. J. L., Serné, E. H., van der Horst-Bruinsma, I. E., Dijkmans, B. A. C., Smulders, Y. M., & Nurmohamed, M. T. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.086777 · Cited by 118
Altered synaptic function in Alzheimer's disease
Bell, K. F. S., & Cuello, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.045 · Cited by 117
Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease
Tobinick, E. L., & Gross, H. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-27 · Cited by 111
Self-citation
The cerebrospinal venous system: anatomy, physiology, and clinical implications.
Tobinick, E. L., & Vega, C. (2006) · PubMed · Cited by 109
Self-citation
Permeability of the Blood-Brain Barrier to Soluble Cytokine Receptors
Banks, W. A., Plotkin, S. R., & Kastin, A. J. (1995) · NeuroImmunoModulation · doi:10.1159/000096887 · Cited by 105
The Alzheimer's Disease Assessment Scale: Evaluation of Psychometric Properties and Patterns of Cognitive Decline in Multicenter Clinical Trials of Mild to Moderate Alzheimer's Disease
Doraiswamy, P. M., Kaiser, L., Bieber, F., & Garman, R. L. (2001) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200110000-00003 · Cited by 105
A Cross-Sectional Study of the Effects of Age, Education, and Gender on the Boston Naming Test
Zec, R. F., Burkett, N. R., Markwell, S. J., & Larsen, D. L. (2007) · The Clinical Neuropsychologist · doi:10.1080/13854040701220028 · Cited by 95
Restraining tumor necrosis factor-alpha by thalidomide prevents the Amyloid beta-induced impairment of recognition memory in mice
Alkam, T., Nitta, A., Mizoguchi, H., Saito, K., Seshima, M., Itoh, A., Yamada, K., & Nabeshima, T. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.12.014 · Cited by 94
Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients
Tobinick, E. L., & Davoodifar, S. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125004286 · Cited by 93
Self-citation
Tumor Necrosis Factor α and Interleukin 10 Promoter Region Polymorphisms and Risk of Late-Onset Alzheimer Disease
Ramos, E. M., Lin, M.-T., Larson, E. B., Maezawa, I., Tseng, L., Edwards, K. L., Schellenberg, G. D., Hansen, J. A., Kukull, W. A., & Jin, L. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.1165 · Cited by 87
Tumor necrosis factor-α−308A/G polymorphism is associated with age at onset of Alzheimer's disease
Lio, D., Annoni, G., Licastro, F., Crivello, A., Forte, G. I., Scola, L., Colonna‐Romano, G., Candore, G., Arosio, B., Galimberti, L., et al. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.015 · Cited by 84
Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?
Small, D. H. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.006 · Cited by 83
Diodrast Studies of the Vertebral and Cranial Venous Systems to Show Their Probable Role in Cerebral Metastases
Anderson, R. H. (1951) · Journal of neurosurgery · doi:10.3171/jns.1951.8.4.0411 · Cited by 81
TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer’s disease
Edwards, M. M., & Robinson, S. R. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0479-5 · Cited by 79
Adalimumab-associated multiple sclerosis.
Grimaldi‐Bensouda, L., Mulleman, D., Valat, J., & Autret‐Leca, E. (2007) · PubMed · Cited by 76
Association between the TNFα‐308 A/G polymorphism and the onset‐age of Alzheimer disease
Álvarez, V., Mata, I. F., González, P., Lahoz, C., Martínez, C., Peña, J., Guisasola, L. M., & Coto, E. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10515 · Cited by 75
Perispinal TNF-alpha inhibition for discogenic pain
Tobinick, E. L., & Britschgi-Davoodifar, S. (2003) · Swiss Medical Weekly · doi:10.4414/smw.2003.10163 · Cited by 75
Self-citation
Regional transport of TNF-α across the blood-brain barrier in young ICR and young and aged SAMP8 mice
Banks, W. A., Moinuddin, A., & Morley, J. E. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00220-2 · Cited by 73
TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels
Laws, S. M., Perneczky, R., Wagenpfeil, S., Müller, U., Förstl, H., Martins, R. N., Kurz, A., & Riemenschneider, M. J. (2005) · Human Mutation · doi:10.1002/humu.20180 · Cited by 72
Exogenous tumor necrosis factor‐α rapidly alters synaptic and sensory transmission in the adult rat spinal cord dorsal horn
Youn, D., Wang, H., & Jeong, S. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21726 · Cited by 69
Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits
Hu, W., Ranaivo, H. R., Roy, S. M., Behanna, H. A., Wing, L. K., Munoz, L., Guo, L., Eldik, L. J. V., & Watterson, D. M. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.10.028 · Cited by 65
Perispinal Etanercept for Treatment of Alzheimers Disease
Tobinick, E. L. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018217 · Cited by 64
Self-citation
Exploring the Validity of the Comprehensive Trail Making Test
Smith, S. R., Servesco, A. M., Edwards, J. W., Rahban, R., Barazani, S., Nowinski, L. A., Little, J. A., Blazer, A. L., & Green, J. G. (2008) · The Clinical Neuropsychologist · doi:10.1080/13854040701399269 · Cited by 62
Comprehensive Trail Making Test (CTMT)By Cecil R. Reynolds. Austin, Texas: PRO-ED, Inc., 2002
Moses, J. A. (2004) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2004.02.004 · Cited by 59
Perispinal etanercept for neuroinflammatory disorders
Tobinick, E. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.005 · Cited by 56
Self-citation
Epileptogenesis due to glia-mediated synaptic scaling
Savin, C., Triesch, J., & Meyer‐Hermann, M. (2008) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0387 · Cited by 52
The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
Chiarini, A., Prà, I. D., Jf, W., & Armato, U. (2006) · PubMed · Cited by 50
Cross‐national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO‐HARPID)
Verhey, F. R. J., Houx, P. J., van Lang, N., Huppert, F. A., Stoppe, G., Saerens, J., Böhm, P., Vreese, L. P. D., Nordlund, A., Dedeyn, P. P., et al. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1035 · Cited by 48
Multiple Sclerosis Onset during Etanercept Treatment
Gómez-Gallego, M., Meca-Lallana, J. E., & Fernández-Barreiro, A. (2007) · European Neurology · doi:10.1159/000109576 · Cited by 48
Targeted etanercept for treatment-refractory pain due to bone metastasis: Two case reports
Tobinick, E. L. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80219-9 · Cited by 43
Self-citation
Die Venensysteme der menschlichen Wirbelsäule : Morphologie und funktionelle Bedeutung
Hj, C. (1961) · Medical Entomology and Zoology · Cited by 37
Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging
Tobinick, E. L., Chen, K., & Chen, X. S. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-28 · Cited by 37
Self-citation
Glutamate induces the expression and release of tumor necrosis factor-α in cultured hypothalamic cells
De, A., Krueger, J. M., & Simasko, S. M. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.044 · Cited by 32
Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.
Tobinick, E. L. (2008) · PubMed · Cited by 28
Self-citation
Mechanisms of Synaptic Homeostasis in Alzheimers Disease
Small, D. H. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480573 · Cited by 28
Verbal Fluency Patterns in Two Subgroups of Patients With Alzheimer's Disease
Fisher, N., Tierney, M. C., Rourke, B. P., & Szalai, J. P. (2004) · The Clinical Neuropsychologist · doi:10.1080/13854040490507235 · Cited by 24
Antibody-bound β-amyloid precursor protein stimulates the production of tumor necrosis factor-α and monocyte chemoattractant protein-1 by cortical neurons
Mbebi, C., de Aguilar, J. G., Sée, V., Dupuis, L., Frossard, N., Mercken, L., Pradier, L., Larmet, Y., & Loeffler, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.11.010 · Cited by 14
Organization of the zona incerta in the macaque: An electron microscopic study
Ma, T. P., Johnson, J. C., & Hoskins, G. A. (1997) · The Anatomical Record · doi:10.1002/(sici)1097-0185(199710)249:2 · Cited by 9
Blurred Vision as the only Symptom of a Positive Epidural Test Dose
Vallejo, M. C., Beaman, S. T., & Ramanathan, S. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000199174.30944.b4 · Cited by 7
Cross-Validation of the Two- and Three-Subtest Short Forms of the Wechsler Memory Scale-Revised
Hilsabeck, R. C., Schrager, D. A., & Gouvier, W. D. (1999) · Applied Neuropsychology · doi:10.1207/s15324826an0604_8 · Cited by 4
WITHDRAWN: PET Imaging Reveals that Etanercept Crosses the Blood-Cerebrospinal Fluid but not the Blood-Brain Barrier: Implications for Alzheimer's Disease.
McGeer, P. L., Tobinick, E. L., Kornelsen, R. A., McCormick, S., Ferreira, C. L., Lapi, S. E., & Ruth, T. J. (2009) · PubMed · doi:10.3233/jad-2009-1081 · Cited by 3
Self-citation

Research works printed but not linked: 8

Chiarini, 2006, Ital J Anat Embryol, 111, 221
Tobinick, 2008, Medscape J Med, 10, 135
Bohac, 2002, Neurobiol Aging, 23, S1
Tobinick, 2006, MedGenMed, 8, 53
Batson, 1957, Am J Roentgenol, 78, 195
Tobinick, 2003, Swiss Med Wkly, 133, 170
Tobinick, 2006, MedGenMed, 8, 25
Baldo, 1998, Neuropsychology, 12, 259, 10.1037/0894-4105.12.2.259 · DOI · Paper page

Sorted by citations

Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
Glial contributions to neurodegeneration in tauopathies
Leyns, C. E. G., & Holtzman, D. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0192-x · Cited by 409
RETRACTED: Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
Rauf, A., Badoni, H., Abu‐Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., Semwal, P., Wilairatana, P., & Mubarak, M. S. (2022) · Molecules · doi:10.3390/molecules27103194 · Cited by 316
Retracted
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 276
TNFα in synaptic function: switching gears
Santello, M., & Volterra, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.06.001 · Cited by 253

See all 118

Authors: Tobinick, E.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Tobinick, Edward
ORCID: Tobinick, Edward
Venue: CNS Drugs
Publisher: Springer Science and Business Media LLC
Published: 2009-09
Volume: 23
Issue: 9
Pages: 713-725
ISSN: 1172-7047 (ISSN-L)
DOI: 10.2165/11310810-000000000-00000
OpenAlex: W2053730308
Cited by: 117
References: 115
Citations by year: 2026: 2 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 9 · 2016: 5 · 2015: 11 · 2014: 9 · 2013: 10 · 2012: 11
FWCI: 1.10
Type: journal article
Language: en
Open access: closed
Locations: CNS Drugs (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: TNF-α, Alzheimer's disease, etanercept, anti-TNF therapy, gliotransmitters, synaptic dysfunction, amyloidogenesis, microvascular dysfunction, primary progressive aphasia
MeSH terms: Etanercept, Alzheimer Disease, Animals, Brain, Humans, Immunoglobulin G, Synaptic Transmission, Risk Factors, Tumor Necrosis Factor-alpha, Drug Delivery Systems, Receptors, Tumor Necrosis Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease: Rationale and Current Evidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks